€50.75
0.10% yesterday
Borsa Italiana, Sep 27, 05:35 pm CET
ISIN
IT0003828271
Symbol
REC
Sector
Industry

Recordati Stock price

€50.75
-0.65 1.26% 1M
-0.99 1.91% 6M
+1.92 3.93% YTD
+6.72 15.26% 1Y
+0.55 1.10% 3Y
+11.40 28.97% 5Y
+37.73 289.78% 10Y
Borsa Italiana, Closing price Fri, Sep 27 2024
+0.05 0.10%
ISIN
IT0003828271
Symbol
REC
Sector
Industry

Key metrics

Market capitalization €10.46b
Enterprise Value €11.93b
P/E (TTM) P/E ratio 27.00
EV/FCF (TTM) EV/FCF 26.52
EV/Sales (TTM) EV/Sales 5.37
P/S ratio (TTM) P/S ratio 4.70
P/B ratio (TTM) P/B ratio 5.79
Dividend yield 2.37%
Last dividend (FY23) €1.20
Revenue growth (TTM) Revenue growth 10.90%
Revenue (TTM) Revenue €2.22b
EBIT (operating result TTM) EBIT €589.39m
Free Cash Flow (TTM) Free Cash Flow €450.00m
Cash position €200.58m
EPS (TTM) EPS €1.88
P/E forward 22.32
P/S forward 4.50
EV/Sales forward 5.13
Show more

Is Recordati a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Recordati Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Recordati forecast:

4x Buy
40%
5x Hold
50%
1x Sell
10%

Analyst Opinions

10 Analysts have issued a Recordati forecast:

Buy
40%
Hold
50%
Sell
10%

Financial data from Recordati

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
2,224 2,224
11% 11%
100%
- Direct Costs 732 732
20% 20%
33%
1,492 1,492
7% 7%
67%
- Selling and Administrative Expenses 472 472
2% 2%
21%
- Research and Development Expense 276 276
15% 15%
12%
745 745
8% 8%
33%
- Depreciation and Amortization 155 155
14% 14%
7%
EBIT (Operating Income) EBIT 589 589
6% 6%
27%
Net Profit 387 387
0% 0%
17%

In millions EUR.

Don't miss a Thing! We will send you all news about Recordati directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Recordati SpA engages in the research, development, manufacturing, and marketing of pharmaceuticals. It operates through the following segments: Specialty & Primary Care and Rare Diseases Pharmaceuticals. The Specialty & Primary Care segment is related to pharmaceutical chemicals business. The Rare Diseases Pharmaceuticals segment, which relates to the Rare Diseases treatment. The company was founded by Giovanni Recordati in 1926 and is headquartered in Milan, Italy.

Head office Italy
CEO Robert Koremans
Employees 4,455
Founded 1996
Website www.recordati.it

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today